Yuval Cohen serves as Executive at Corbus Pharmaceuticals Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Yuval Cohen has executed 52 insider transactions totaling $3.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 4, 2014 involved purchasing 500 shares valued at $1.6K.
Yuval Cohen currently holds 150,000 shares of Corbus Pharmaceuticals Holdings, Inc. (CRBP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Yuval Cohen has been a net seller of CRBP stock. They have purchased $159.4K and sold $3.4M worth of shares.
Yuval Cohen's most recent insider trade was on Dec 4, 2014, when they purchased 500 shares at $3.30 per share.
Get notified when new Form 4 filings are submitted
| $3.20 |
| Discretionary |